AbbVie Inc.’s blockbuster drug Humira will remain available to members of UnitedHealth Group Inc.’s pharmacy benefits manager alongside up to three other similar medications, as one of the world’s top-selling treatments faces its first competitors in the US next year.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
